Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISTICH: Minocycline in Acute Spontaneous Intracerebral Hemorrhage
NCT07338175Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2026
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in intracerebral hemorrhage (ICH), sponsored by Beijing Tiantan Hospital. Started Apr 2026; status: recruiting.
02
Drugs
minocycline
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07338175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338175.